skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

About Hardik

USA

+5 year(s) experience

Hardik Patel is the Therapeutic Area Director for Oncology coverage within Datamonitor Healthcare and Biomedtracker. He helps clients to better understand the current clinical and commercial landscape in various indications, and provides insight on how this may change in the future.

Hardik’s interest in oncology stems from the cutting-edge drug development caused by the critical need for more effective treatments. He aims to provide clients with the tools that will assist them in making greater contributions to the advancement of oncology treatments.

 

Since joining Datamonitor Healthcare in 2013, Hardik has contributed content and insights on diseases within the oncology, respiratory, and immunology and inflammation therapeutic areas.

 

He holds a BSc in Biomedical Engineering and a Masters in Engineering and Management, both from Case Western Reserve University.


Analyst Articles

Articles by Hardik

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Non-Small Cell Lung Cancer: Evolution of Immunotherapies

    19 Oct 2015

    Non-Small Cell Lung Cancer: Evolution of Immunotherapies

    Immunotherapies are one of the fastest growing treatment algorithms in pharma at the moment, and non-small cell lung cancer (NSCLC) is just one area of oncology that is going to make the transition into being dominated by this type of therapy.